Telisotuzumab Vedotin: clinical trials recruiting now
3
Recruiting trials
3
Conditions studied
32
US states with sites
34
Countries
Phase breakdown
Phase 2 2
Phase 3 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer · Telisotuzumab Vedotin for Lung cancer | 3 |
| Non Small Cell Lung Cancer | 2 |
| Lung Non-Small Cell Carcinoma | 1 |
Recruiting trials involving Telisotuzumab Vedotin
- A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer
Common questions
How many recruiting trials involve Telisotuzumab Vedotin?
3 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.